Statins for prostate cancer: when and how much?

Clin Cancer Res. 2021 Jul 19:clincanres.1891.2021. doi: 10.1158/1078-0432.CCR-21-1891. Online ahead of print.ABSTRACTStatins have plausible biological effects against prostate cancer cells and are associated with improved disease-specific mortality. In current randomized placebo-controlled trial low-dose atorvastatin caused no difference in relapses after radical prostatectomy in Asian men. Future trials should study higher statin doses at later disease stages with survival as the endpoint.PMID:34281913 | DOI:10.1158/1078-0432.CCR-21-1891
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Source Type: research